Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2005
11/22/2005US6967245 Ucp5
11/22/2005US6967102 skeletal muscle proliferation; invention relates to nitric oxide as a modulator of skeletal muscle precursor cell activation, and to uses of nitric oxide to improve muscle formation and repair in normal and disease states
11/22/2005US6967095 DNA sequence encoding human secretory type PLA2 protein (IID type) from human spleen cDNA library
11/22/2005US6967094 Peptide for use in treatment of cancer, parkinson's and metabolic disorders
11/22/2005US6967087 Obligately symbiotic thermophile symbiobacterium toebii SC-1 producing thermostable L-tyrosine phenol-lyase and L-tryptophan indole-lyase and a method for screening its relative bacteria
11/22/2005US6967086 Method for determining the presence or absence of respiring cells on a three-dimensional scaffold
11/22/2005US6967085 a first cationic polymer that has intrinsic viscosity of not more than 2 dl/g, (e.g., polydiallyldimethylammonium chloride) and a second polymer, which is cationic or non-ionic and has inintrinsic viscosity of at least 4 dl/g
11/22/2005US6967084 Accurate diagnosis of infections; obtain nose secretions, monitor contents, determine type of infection
11/22/2005US6967079 Pyrimidine derivatives for labeled binding partners
11/22/2005US6967078 nuclear transcriptional regulation following BMP signal transduction; screening for a compound that disrupts transcriptional repression of a gene
11/22/2005US6967076 A reporter sequence consists of a reporter gene whose expression is regulated by a protein specific to HIV viruses, expressed from a genome of an HIV virus upon infection of a cell tranduced by genetic engineered viral vector
11/22/2005US6967075 HCV replicase complexes
11/22/2005US6967016 Method of determining therapeutic activity and/or possible side-effects of a medicament
11/22/2005US6966977 Whole blood is measured, wherein plasma of blood, with hemocytes thereof having been filtered out, is allowed to quickly reach an electrode system; high speed, accuracy
11/22/2005CA2267639C Synthetic hpv16 virus-like particles
11/17/2005WO2005109304A2 Small molecules and a pharmacophore model for inhibition of anthrax lethal factor
11/17/2005WO2005109002A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/17/2005WO2005109001A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/17/2005WO2005109000A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/17/2005WO2005108998A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor beta-3 adreno (adrb3)
11/17/2005WO2005108997A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 6 (dpp6)
11/17/2005WO2005108996A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 10 (dpp10)
11/17/2005WO2005108994A1 Fluorescence resonance energy transfer enzyme substrates
11/17/2005WO2005108993A2 Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 6 (map3k6)
11/17/2005WO2005108990A2 Methods of treating demyelinating disorders
11/17/2005WO2005108982A1 Methods for identifying compounds for treating diabetes mellitus
11/17/2005WO2005108979A1 Kit for assaying potency of peripheral mononuclear blood cell to bind to polysaccharide
11/17/2005WO2005108968A1 Biosensor, container for biosensor, and biosensor measuring apparatus
11/17/2005WO2005108949A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/17/2005WO2005108627A2 Electrophoretic interactive spectral methods and devices for the detection and/or characterization of biological particles
11/17/2005WO2005108626A2 Mutants of staphylococcal mrs and methods of use
11/17/2005WO2005108625A2 Method for preparing substrates having immobilized molecules and substrates
11/17/2005WO2005108624A2 Use of hla-g genotyping in immune-mediated conditions
11/17/2005WO2005108623A2 Mn/ca ix/ ca9 and renal cancer prognosis
11/17/2005WO2005108622A2 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
11/17/2005WO2005108621A1 Methods and compositions for cancer diagnosis
11/17/2005WO2005108620A2 Processing polynucleotide-containing samples
11/17/2005WO2005108619A2 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
11/17/2005WO2005108618A2 Methods and kits for methylation detection
11/17/2005WO2005108617A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005WO2005108616A1 Use of il-17 expression to predict skin inflammation; methods of treatment
11/17/2005WO2005108615A2 Nucleic-acid programmable protein arrays
11/17/2005WO2005108614A2 Reversible and chemically programmable micelle assembly with dna block-copolymer amphiphiles
11/17/2005WO2005108613A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
11/17/2005WO2005108612A2 Nanoscale biosensor device, system and technique
11/17/2005WO2005108611A2 Methods and compositions for the amplification of mutations in the diagnosis of cystic fibrosis
11/17/2005WO2005108610A2 Methods for the selection of subjects for multiple sclerosis therapy
11/17/2005WO2005108609A1 Method for identification and analysis of certain molecules using the dual function of single strand nucleic acid
11/17/2005WO2005108608A1 Method for isolating nucleic acid isoforms
11/17/2005WO2005108607A1 Compositions and methods for treating disorders associated with abnormal phosphate metabolism
11/17/2005WO2005108606A2 Method of examining the functional genic variability of hiv and kit for implementing same
11/17/2005WO2005108605A2 Polymorphisms in abcb1 associated with a lack of clinical response to medicaments
11/17/2005WO2005108604A2 Device and method for detecting molecular interactions
11/17/2005WO2005108603A1 Senp1 as a marker for cancer
11/17/2005WO2005108602A1 Method for the isolation of specific molecules which bind in a highly selective manner to selected target molecules
11/17/2005WO2005108601A1 Detection of rna with micro-arrays
11/17/2005WO2005108600A1 Gm3 synthase as a therapeutic target in microvascular complications of diabetes
11/17/2005WO2005108599A2 Compositions and methods for treatment of protein misfolding diseases
11/17/2005WO2005108598A1 Assay for drug discovery based on in vitro differentiated cells
11/17/2005WO2005108588A1 Novel hiv-based recombinant viral clones and use thereof in analytical methods
11/17/2005WO2005108582A1 DETECTING DISEASE ASSOCIATION WITH ABERRANT GLYCOGEN SYNTHASE KINASE 3β EXPRESSION
11/17/2005WO2005108579A1 Polynucleotides for the detection of staphylococcus aureus
11/17/2005WO2005108578A1 Polynucleotides for the detection of escherichia coli
11/17/2005WO2005108575A1 T-type calcium channel splice variant compositions and methods
11/17/2005WO2005108574A1 Gm1 PROMOTER AND USE THEREOF
11/17/2005WO2005108571A1 Micro-reactor for testing, genetic testing apparatus, and genetic testing method
11/17/2005WO2005108569A1 Method of determining breed of pig
11/17/2005WO2005108547A1 Patterned cell network substrate interface and methods and uses thereof
11/17/2005WO2005108545A2 Devices for culturing anaerobic microorganisms and methods of using the same
11/17/2005WO2005108427A2 Method for producing soluble mhc proteins
11/17/2005WO2005108420A1 Cancer associated antigens
11/17/2005WO2005107796A2 Cellular permissivity factor for viruses, and uses thereof
11/17/2005WO2005107792A2 Compositions and methods for treatment of protein misfolding diseases
11/17/2005WO2005107782A2 Use of a modulator of gene expression in the treatment of cancer
11/17/2005WO2005107430A2 Internal control in situ hybridization
11/17/2005WO2005107396A2 Novel compositions and methods in cancer
11/17/2005WO2005093045A3 Cell concentration and pathogen recovery
11/17/2005WO2005089080A3 Method and kit for screening, pharmaceutical compositions and method for treatment of autoimmune disorders
11/17/2005WO2005072205A3 Image analysis and assay system
11/17/2005WO2005071102A3 Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators
11/17/2005WO2005071100A3 Method for determination of protein modifying or demodifying activity and suitable materials thereof
11/17/2005WO2005068655A3 Methods of assessing a tissue inflammatory response using expression profiles of endothelial cells
11/17/2005WO2005059097A3 Methods for high fidelity production of long nucleic acid molecules
11/17/2005WO2005056829A3 Method for diagnosis/prognosis of breast cancer
11/17/2005WO2005049865A3 Markers for stem cells and transplantation compatibility
11/17/2005WO2005049648A3 Chimeric or fusion constructs of insulin-like growth factor binding proteins as chemotherapeutic agents
11/17/2005WO2005049063A3 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
11/17/2005WO2005048823A3 Modeling of systemic inflammatory response to infection
11/17/2005WO2005045394A3 Silicone composition for biocompatible membrane
11/17/2005WO2005042716A3 Nucleic acid binding oligonucleotides
11/17/2005WO2005023835A3 Modulators of transmembrane protease serine 6
11/17/2005WO2005021044A3 Nanoparticles for delivery of nucleic acids and stable double-stranded rna
11/17/2005WO2005016227A3 Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof
11/17/2005WO2005009397A3 Human lymphocyte vaccine adjuvant
11/17/2005WO2005001141A3 Methods and nucleic acids for analyses of colorectal cell proliferative disorders
11/17/2005WO2004108945A3 Oligonucleotide modulation of cell adhesion
11/17/2005WO2004103316A3 Orp9, a novel therapeutic target for increasing hdl levels
11/17/2005WO2004097369A3 Fragmentation-based methods and systems for de novo sequencing
11/17/2005WO2004070006A3 Nucleic acid antigens embedded in thermoplastic
11/17/2005WO2004063718A3 Assembly of single use sensing elements
1 ... 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 ... 3003